Recent clinical trials show urolithin A, a compound derived from molecules in pomegranates, can slow the aging process. Urolithin A improves mitochondrial function following oral consumption.
Researchers discover an experimental Alzheimer's disease drug appears to slow key features of the aging process, including memory loss and improved a number of physiological features.
